Jeffrey S. Hatfield
CIK 1609879 · Chief Executive Officer · last filed 2026-05-28
Jeffrey S. Hatfield is a Chief Executive Officer who has filed 33 SEC Form 4 insider transactions across 8 companies since 2014. The most recent filing, for VIR, was dated May 28, 2026. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $342.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$342.7K
8
33
-$1.42M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VIR | Director | 39,806 | $8.61 | $342.7K | $0 | 7 | 2026-05-28 |
| VRDN | Director | — | $16.35 | — | $0 | 1 | 2021-02-08 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Director | — | — | — | $0 | 3 | 2020-05-22 |
| LIFE | Director | — | $15.61 | — | $0 | 5 | 2020-05-08 |
| Larimar Therapeutics, Inc. (ZFGN) Delisted | Chief Executive Officer | — | — | — | $0 | 4 | 2019-01-24 |
| INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Director | — | $0.32 | — | $0 | 2 | 2018-01-23 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Chief Executive Officer | 244,996 | — | — | -$1.42M | 10 | 2016-10-25 |
| AMBIT BIOSCIENCES CORP (AMBI) Delisted | Director | — | $0.54 | — | $0 | 1 | 2014-11-12 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-28 | VIR | Grant (A) | +8,000 | $0 | EDGAR |
| 2025-06-02 | VIR | Grant (A) | +8,000 | $0 | EDGAR |
| 2024-06-03 | VIR | Grant (A) | +8,000 | $0 | EDGAR |
| 2023-05-24 | VIR | Grant (A) | +6,027 | $0 | EDGAR |
| 2022-05-25 | VIR | Grant (A) | +6,405 | $0 | EDGAR |
| 2021-05-25 | VIR | Grant (A) | +3,374 | $0 | EDGAR |
| 2021-02-08 | VRDN | Grant (A) | — | $0 | EDGAR |
| 2020-12-11 | VIR | Grant (A) | — | $0 | EDGAR |
| 2020-05-22 | Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-08 | LIFE | Grant (A) | — | $0 | EDGAR |